Hong Xiao

7PUBLICATIONS
28CO-AUTHORS
Medical genetics (excl. cancer genetics)Predictive and prognostic markersNutritional epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Information systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 14, 2024
Treatment characteristics and outcomes in lower-risk, non-del(5q) myelodysplastic syndromes: findings from a medical record review in the USA, Canada and Europe.

Maria Diez-Campelo, Aylin Yucel, Ravi K Goyal

|May 11, 2024
A Systematic Literature Review of Predictors of Erythropoiesis-Stimulating Agent Failure in Lower-Risk Myelodysplastic Syndromes.

Ralph Boccia, Hong Xiao, Caroline von Wilamowitz-Moellendorff

|Feb 14, 2024
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study.

Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei

|Sep 15, 2023
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649.

Markus Moehler, Hong Xiao, Steven I Blum

|Jan 05, 2022
Patient and caregiver socioeconomic burden of first-line systemic therapy for advanced gastroesophageal adenocarcinoma.

Hong Xiao, David Bertwistle, Keerun Khela

|Jan 09, 2020
Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility.

Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei

Pageof 2

Frequent Collaborators

2 joint publications

Monica A Muñoz

2 joint publications

Gerald J Dal Pan

2 joint publications

Yu-Jung Jenny Wei

2 joint publications

Chris Delcher